SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

March 01, 2012 08:35 ET

MMRGlobal Announces Fourth Quarter and Year-End 2011 Earnings Release Date and Conference Call

Company to Discuss $5 Million Licensing Fee Invoiced in Q4

LOS ANGELES, CA--(Marketwire - Mar 1, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic document management and imaging systems for healthcare professionals, today announced plans to release its fourth quarter and year-end financial results for the period ended December 31, 2011 on Friday, March 30, 2012 after the market closes. The call will be hosted by Robert H. Lorsch, Chairman and Chief Executive Officer, and Ingrid Safranek, Chief Financial Officer.

In connection with the fourth quarter and fiscal year 2011 earnings release, the Company has scheduled a conference call and webcast on March 30th at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. In addition to discussing financial results, management will discuss the $5 million it invoiced to Surgery Center Management in the fourth quarter for licensing fees, the relationship with UST Global and the progress of embedding the Company's patented PHR in EMR service offerings of UST, distribution of the Prepaid Personal Health Record cards, the status of the existing deployment of 4medica inside the MyMedicalRecords PHR, the deployment of Telemedicine services inside the MyMedicalRecords PHR, results from the Company's participation in the upcoming Military Electronic Health Records Conference March 15-16 in Washington, D.C. (, the launch of strategic offerings to veterans at the Company's website, the status of a launch in China embedding the MMR Personal Health Record in two hospitals already deploying UNIS systems, and licensing efforts in Australia and other developments with regard to licensing the Company's intellectual property. The Company also plans on demonstrating MMR's Android app for handheld devices and will discuss other business yet to be announced. Following the presentation, management will take questions from investors. The call is scheduled to last for up to 90 minutes and a link to the replay will be available in MMRGlobal's Investor Relations section for approximately two weeks following the live broadcast.

Details on how to access the call will be posted on the Company's Investor Relations site at, or you can contact Investor Relations at To automatically receive the Company's filings, press releases and updates on the call, register at Detailed reminders will also be issued in advance of the live webcast for the convenience of investors and other interested parties.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId®/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit View demos and video tutorials of the Company's products and services at

Forward-Looking Statements

This press release contains certain forward-looking statements. The words "anticipate," "expect," "believe," "plan," "intend," "will" and similar expressions are intended to identify such statements. Although the forward-looking statements in this press release reflect the good faith judgment of our management, such statements are subject to various risks and uncertainties, including but not limited to those discussed or incorporated by reference herein. Actual results and the timing of selected events may differ materially from those anticipated in these forward-looking statements. The forward-looking statements included herein are necessarily based on various assumptions and estimates and are inherently subject to various risks and uncertainties, including risks and uncertainties relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners and competitors and legislative, judicial and other governmental authorities and officials. Assumptions related to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control. Any of such assumptions could be inaccurate. Except as required by applicable law, we disclaim any duty to update any forward-looking statement to reflect events or circumstances that occur after the date on which such statement is made.

Contact Information